Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 67, Issue 5-6, 1998, Pages 391-402

  Skaar, Todd C ^a,b   Prasad, Sarada C ^a   Sharareh, Sheri ^a   Lippman, Marc E ^a   Brünner, Nils ^a,c   Clarke, Robert ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN REGULATED PROTEIN; NUCLEOPHOSMIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL NUCLEUS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0032457510     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00142-3     Document Type: Article

References (58)

1. 1. Clarke R., Dickson R. B. and Brünner N., The process of malignant progression in human breast cancer. Ann. Oncol. 1 (1990) 401-407.
2. 2. Clarke R., Skaar T., Baumann K., Leonessa K., James M. R., Lippman J., Thompson E. W., Freter C. and Brünner N., Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res. Treat. 31 (1994) 237-248.
3. 3. Clarke R. and Brünner N., Acquired estrogen independence and antiestrogen resistance in breast cancer: estrogen receptor-driven phenotypes?. Trends Endocrinol. Metab. 7 (1996) 25-35.
4. 4. Velculescu V. E., Zhang L., Vogelstein B. and Kinzler K. W., Serial analysis of gene expression. Science 270 (1995) 484-487.
5. 5. Liang P. and Pardec A. B., Differential display of eucaryotic messenger RNA by means of the polymerase chain reaction. Science 257 (1992) 967-971.
6. 6. Huber L. A., Mapping cells and sub-cellular organelles on 2-D gels: 'new tricks for an old horse'. FEBS Lett. 369 (1995) 122-125.
7. 7. Hanash S. M. and Strahler J. R., Advances in two-dimensional electrophoresis. Nature 337 (1989) 485-486.
8. 8. Fargnoli J., Holbrook N. J. and Fornace A.J. Jr, Low-ratio hybridization subtraction. Analyt. Biochem. 187 (1990) 364-373.
9. 9. Sambrook, J., Fritsch, E. F. and Maniatis T., Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York, 1989.
10. 10. Brünner N., Boulay V., Fojo A. .Li, Freter C., Lippman M. E. and Clarke R., Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res. 53 (1993) 283-290.
11. 11. Khanuja P. S., Lehr J. E., Soule H. D., Gehani S. K., Noto A. C., Choudhury S., Chen R. and Pienta K. J., Nuclear matrix proteins in normal and breast cancer cells. Cancer Res. 53 (1993) 3394-3398.
12. 12. Worland P. J., Bronzert D., Dickson R. B., Lippman M. E., Hampton L. and Thorgeirsson S. S., Secreted and cellular polypeptide patterns of MCF-7 human breast cancer cells following either estrogen stimulation or v-H-ras transfection. Cancer Res. 49 (1989) 51-57.
13. 13. Maloney T. M., Paine P. L. and Russo J., Polypeptide composition of normal and neoplastic human breast tissues and cells analyzed by two dimensional gel electrophoresis. Breast Cancer Res. Treat. 14 (1989) 337-348.
14. 14. Wirth P. J., Egilsson V., Gunadson V., Ingvarrson S. and Thorgeirsson S. S., Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis. Breast Cancer Res. Treat. 10 (1987) 177-189.
15. 15. Stastny J., Prasad R. and Fosslien E., Tissue proteins in breast cancer, as studied by use of two-dimensional electrophoresis. Clin. Chem. 30 (1984) 1914-1918.
16. 16. Clarke R., Brünner N., Katzenellenbogen B. S., Thompson E. W., Norman M. J., Koppi C., Paik S., Lippman M. E. and Dickson R. B., Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells. Proc. Natl Acad. Sci. USA 86 (1989) 3649-3653.
17. 17. Thompson E. W., Brünner N., Torri J., Johnson M. D., Boulay V., Wright A., Lippman M. E., Steeg P. S. and Clarke R., The invasive and metastatic properties of hormone-independent and hormone-responsive variants of MCF-7 human breast cancer cells. Clin. Exp. Metastasis 11 (1993) 15-26.
18. 18. Clarke R., Brünner N., Thompson E. W., Glanz P., Katz D., Dickson R. B. and Lippman M. E., The inter-relationships between ovarian-independent growth, antiestrogen resistance and invasiveness in the malignant progression of human breast cancer. J. Endocrinol. 122 (1989) 331-340.
19. 19. Saceda M., Lippman M. E., Chambon P., Lindsey R. K., Puente M. and Martin M. B., Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 2 (1988) 1157-1162.
20. 20. Brünner N., Frandsen T. L., Holst-Hansen C., Bei M., Thompson E. W., Wakeling A. E., Lippman M. E. and Clarke R., MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant which retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res. 53 (1993) 3229-3232.
21. 21. Bindal R. D., Carlson K. E., Katzenellenbogen B. S. and Katzenellenbogen J. A., Lipophylic imputities, not phenolsulfonphthalein, account for the estrogenic properties in commercial preparations of phenol red. J. Steroid Biochem. 31 (1988) 287-293.
22. 22. Darbre P., Yates J., Curtis S. and King R. J. B., Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43 (1983) 349-354.
23. 23. Wakeling A. E., Dukes M. and Bowler J., A potent specific pure antiestrogen with clinical potential. Cancer Res. 51 (1991) 3867-3873.
24. 24. O'Farrell P. H., High resolution two-dimensional gel electrophoresis of proteins. J. Biol. Chem. 250 (1975) 4007-4021.
25. 25. Morrissey J. H., Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Analyt. Biochem. 117 (1981) 307-310.
26. ++ ions on nuclear integrity and subcellular distribution of unoccupied oestrogen receptor in breast cancer cells. J. Steroid Biochem. 25 (1986) 619-626.
27. 27. Parekh B. S., Mehta H. B., West M. D. and Montelaro R. C., Preparative elution of proteins from nitrocellulose membranes after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analyt. Biochem. 148 (1985) 87-92.
28. 28. Brauer A. W., Oman C. L. and Margolies M. N., Use of O-Phthalaldehyde to reduce background during automated Edman degradation. Analyt. Biochem. 137 (1984) 134-142.
29. 29. Chan P. K., Chan W.-Y., Yung B.Y.-M., Cook R. G., Aldrich M., Ku D., Goldknopf I. L. and Busch H., Amino acid sequence of a specific antigenic peptide of protein B23. J. Biol. Chem. 261 (1986) 14335-14341.
30. 30. Harlow, E. and Lane, D. Antibodies. A Laboratory Manual. Cold Spring Harbor, New York, 1988.
31. 31. Hames, B. D. One-dimensional polyacrylamide gel electrophoresis. In Gel Electrophoresis of Proteins, eds B. D. Hames and D. Rickwood. IRL Press, Oxford, 1990, pp. 1-147.
32. 32. Chan W.-Y., Liu Q.-R., Borjigin J., Rennert O. M., Tease L. A. and Chan P. K., Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28 (1989) 1033-1039.
33. 33. Chan P. K., Aldrich M. and Busch H., Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation. Exp. Cell Res. 161 (1985) 101-110.
34. 34. Anderson N. L., Esquer-Blasco R., Hofmann J.-P., Meheus L., Raymackers J., Steiner S., Witzmann F. and Anderson N. G., An updated two-dimensional gel database of rat liver proteins useful in gene regulation and drug effect studies. Electrophoresis 16 (1995) 1977-1981.
35. 35. Appel R. D., Sanchez J., Bairoch A., Golaz O., Ravier F., Pasquali C., Hughes G. J. and Hochstrasser D. F., The SWISS-2DPAGE database of two-dimensional polyacrylamide gel electrophoresis, its status in 1995. Nucl. Acid Res. 24 (1996) 180-181.
36. 36. Witzmann F. A., Fultz C. and Lipscomb J., Comparative 2D-electrophoretic mapping of human and rodent hepatic stress proteins as potential biomarkers. Appl. Theoret. Electrophor. 5 (1995) 113-117.
37. 37. Kondo T., Minamino N., Nagamura-Inoue T., Matsumoto M., Taniguchi T. and Tanaka N., Identification and characterization of nucleophosmin/B23/numatrin which binds the antioncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15 (1997) 1275-1281.
38. 38. Subramanian S., Shariff S. and Andrade C., AgNORs and their relationship to cell size, histological grade, lymph node involvement, metastases, and survival pattern in carcinoma of the breast: a study from South India. J. Surg. Oncol 62 (1996) 139-143.
39. 39. Nakayama K. and Abe R., Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer. J. Surg. Oncol. 60 (1995) 160-167.
40. 40. Meehan S. M., Magee H., Carney D. N. and Dervan P. A., The diagnostic value of silver nucleolar organizer region assessment in breast cytology. Anat. Embryol. 101 (1994) 689-693.
41. 41. Lischwe M. A., Smetana K., Olson M. O. J. and Busch H., Proteins C23 and B23 are the major nucleolar silver staining proteins. Life Sci. 25 (1979) 701-708.
42. 42. Tawfic S., Goueli S. A., Olson M. O. J. and Ahmed K., Androgenic regulation of the expression and phosphorylation of prostatic nucleolar protein B23. Cell Mol. Biol. Res. 39 (1993) 43-51.
43. 43. Tawfic S., Olson M. O. J. and Ahmed K., Role of protein phosphorylation in post-translational regulation of protein B23 during programmed cell death in the prostate gland. J. Biol. Chem. 270 (1995) 21009-21015.
44. 44. Patterson S. D., Grossman J. S., D'Andrea P. and Latter G. I., Reduced numatrin/B23/nucleophosmin labeling in apoptotic Jurkat T-lymphoblasts. J. Biol. Chem. 270 (1996) 9429-9436.
45. 45. Feuerstein N. and Randazzo P. A., In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. Exp. Cell Res. 194 (1991) 289-296.
46. 46. Tamura T., Ishihara M., Lamphier M. S., Tanaka N., Oishi I., Alzawa S., Matsuyama T., Mak T. W., Taki S. and Taniguchi T., An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376 (1995) 596-599.
47. 47. Tanaka N., Ishihara M., Lamphier M. S., Nozawa H., Matsuyama T., Mak T. W., Aizawa S., Tokino T., Oren M. and Taniguchi T., Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382 (1996) 816-818.
48. 48. Skaar, T. C. and Clarke, R. Retinoid regulation of the IRF-1 tumor suppressor gene in breast cancer cells. Proc. Am. Assoc. Cancer Res. 1998, Abstract No. 1877.
49. 49. Keane M. M., Ettenberg S. A., Lowrey G. A., Russell E. K. and Lipkowitz S., Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56 (1996) 4791-4798.
50. 50. Meier V. S. and Groner B., The nuclear factor YY1 participates in repression of the β-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction. Mol. Cell Biol. 14 (1994) 128-137.
51. 51. Raught B., Khursheed B., Kazansky A. and Rosen J., YY1 represses β-casein gene expression by preventing the formation of a lactation-associated complex. Mol. Cell Biol. 14 (1994) 1752-1763.
52. 52. Zhou Q., Gedrich R. W. and Engel D. A., Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J. Virol. 69 (1995) 4323-4330.
53. 53. Furlong E. E. M., Rein T. and Martin F., YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite clement, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol. Cell Biol. 16 (1996) 5933-5945.
54. 54. Koike H., Karas R. H., Baur W. E., O'Donnell T.F. Jr and Mendelsohn M. E., Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-rcgulated gene in human vascular smooth muscle cells. J. Vasc. Surg. 23 (1996) 477-482.
55. 55. Peter M., Nakagawa J., Doree M., Labbe J. C. and Nigg E. A., Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60 (1990) 791-801.
56. 56. Beckmann R., Buchner K., Jungblut P. R., Eckerskorn C., Weise C., Hilbert R. and Hucho F., Nuclear substrates of protein kinase C. Eur. J. Biochem. 210 (1992) 45-51.
57. 57. Chan P. K., Liu Q. R. and Durban E., The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II. Biochem. J. 270 (1990) 549-552.
58. 58. Ho T.-Y., Russo J. and Russo I. H., Polypeptide pattern of human breast epithelial cells following human chorionic gonadotropin (hCG) treatment. Electrophoresis 15 (1994) 746-750.